BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1394798)

  • 21. Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.
    Houghton PJ; Houghton JA; Hazelton BJ; Radparvar S
    Invest New Drugs; 1989 Apr; 7(1):59-69. PubMed ID: 2661484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Correlation of antitumor activity with dosage and FUra incorporation into RNA.
    Nord LD; Stolfi RL; Martin DS
    Biochem Pharmacol; 1992 Jun; 43(12):2543-9. PubMed ID: 1378737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
    Houghton JA; Tice AJ; Houghton PJ
    Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination chemotherapy with orally administered UFT and leucovorin (LV)].
    Okabe H; Saito H; Oie S; Nakano K; Uchida J; Takechi T; Takeda S; Kawaguchi Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1645-50. PubMed ID: 1872623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin.
    Rustum YM
    Cancer; 1989 Mar; 63(6 Suppl):1013-7. PubMed ID: 2783877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
    Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
    Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modulation by L-leucovorin of 5-fluorouracil antitumor activity on human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Takahara T; Takeuchi T; Yamaguchi H; Furukawa T; Teramoto T; Kodaira S; Ishibiki K
    Surg Today; 1993; 23(7):615-20. PubMed ID: 8369613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
    Tillman DM; Petak I; Houghton JA
    Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ; Madajewicz S; Herrera L; Rustum YM; Trave F; Creaven P; Mittelman A
    NCI Monogr; 1987; (5):189-92. PubMed ID: 3501541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
    Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM
    Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of a human colon adenocarcinoma xenograft deficient in thymidine salvage.
    Houghton PJ; Houghton JA; Germain G; Torrance PM
    Cancer Res; 1987 Apr; 47(8):2117-22. PubMed ID: 3829001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells.
    Zhang ZG; Rustum YM
    Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of 5-Fluorouracil Cytotoxicity by Pyridoxal 5'-Phosphate and Folinic Acid in Tandem.
    Machover D; Goldschmidt E; Mollicone R; Haghighi-Rad F; Desterke C; Gaston-Mathé Y; Saffroy R; Boucheix C; Dairou J
    J Pharmacol Exp Ther; 2018 Aug; 366(2):238-243. PubMed ID: 29858389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].
    Saito H; Okabe H; Nakano K; Fujioka A; Toko T; Takeda S; Unemi N
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1919-25. PubMed ID: 7487121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
    Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
    J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions.
    Bailey H; Wilding G; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Grem JL; Spriggs DR
    Cancer Chemother Pharmacol; 1992; 30(4):297-302. PubMed ID: 1643698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.